This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nayebpour, M. Articles by Nattel, S. Search for Related Content PubMed PubMed Citation Articles by Nayebpour, M. Articles by Nattel, S.

Circulation, Vol 88, 2632-2645, Copyright © 1993 by American Heart Association

ARTICLES

Effects of adenosine on rate-dependent atrioventricular nodal function. Potential roles in tachycardia termination and physiological regulation

M Nayebpour, J Billette, F Amellal and S Nattel
Department of Physiology, University of Montreal, Quebec, Canada.

BACKGROUND. Adenosine is well known to depress atrioventricular (AV) nodal conduction, but the potential interactions between adenosine and functional AV nodal properties have not been explored. The purpose of the present study was to determine (1) whether exogenous adenosine modifies the rate-dependent properties of the AV node, (2) to what extent such changes underlie the actions of adenosine in an in vitro model of AV reentrant tachycardia (AVRT), and (3) the potential role of endogenous adenosine in rate-induced AV nodal responses. METHODS AND RESULTS. The functional properties of AV nodal recovery (defining the conduction delay of a single premature activation), facilitation (effect of short cycles on subsequent nodal recovery), and fatigue (slowly developing AV nodal delay at a rapid rate) were studied selectively in isolated, superfused rabbit and guinea pig cardiac preparations. Exogenous adenosine increased AV nodal fatigue and attenuated facilitation, resulting in tachycardia-dependent increases in AH interval and AV nodal effective refractory period (AVERP). In experimental AVRT, adenosine caused greater increases in tachycardia cycle length (T) and AVERP as tachycardia rate increased. AVRT was sustained when AVERP/T was < 1, and adenosine suppressed AVRT by increasing the slope of the AVERP/T versus tachycardia rate relation, causing the critical ratio of 1 to be attained at slower rates. A mathematical model incorporating quantitative descriptors of recovery, facilitation, and fatigue accounted for changes in AH interval, AVERP, tachycardia cycle length, and AVERP/T under control conditions and in the presence of adenosine. In the absence of exogenous adenosine, 8- phenyltheophylline (10 mumol/L), an adenosine receptor antagonist, did not alter recovery or facilitation but significantly reduced rate- related fatigue (by 31 +/- 8%, mean +/- SEM, P < .05, in rabbit hearts; 46 +/- 5%, P < .01, in guinea pig hearts). Combined inhibition of adenosine deaminase (with erythro-9-[2-hydroxy-3-nonyl]-adenine hydrochloride, 5 mumol/L) and adenosine uptake (with dipyridamole, 1 mumol/L) increased fatigue in the absence of exogenous adenosine by 57 +/- 20% (P < .05). CONCLUSIONS. We conclude that (1) exogenously administered adenosine increases AV nodal fatigue and reduces facilitation, without altering AV nodal recovery; (2) these changes cause rate-dependent AV nodal depression, which plays a role in adenosine's actions on experimental AVRT; and (3) endogenous adenosine receptor activation plays a role in physiological AV nodal fatigue. Adenosine's ability to terminate reentrant supraventricular tachycardia may be due, at least in part, to its ability to enhance the physiological conduction slowing that results from sustained increases in AV nodal activation rate.

This article has been cited by other articles:

				P. Ballo, D. Bernabo, and S. A. Faraguti Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia Eur. Heart J., August 1, 2004; 25(15): 1310 - 1317. [Abstract] [Full Text] [PDF]

				E. N. Prystowsky, I. Niazi, A. B. Curtis, D. J. Wilber, T. Bahnson, K. Ellenbogen, A. Dhala, D. M. Bloomfield, M. Gold, A. Kadish, et al. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510),a novel A1-adenosine receptor agonist J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1098 - 1102. [Abstract] [Full Text] [PDF]

				A. J Workman, K. A Kane, and A. C Rankin Ionic basis of a differential effect of adenosine on refractoriness in rabbit AV nodal and atrial isolated myocytes Cardiovasc Res, September 1, 1999; 43(4): 974 - 984. [Abstract] [Full Text] [PDF]

				D. M. Dennis, M.J. P. Raatikainen, J. R. Martens, and L. Belardinelli Modulation of Atrioventricular Nodal Function by Metabolic and Allosteric Regulators of Endogenous Adenosine in Guinea Pig Heart Circulation, November 15, 1996; 94(10): 2551 - 2559. [Abstract] [Full Text]

				D. Wang, J. C. Shryock, and L. Belardinelli Cellular Basis for the Negative Dromotropic Effect of Adenosine on Rabbit Single Atrioventricular Nodal Cells Circ. Res., April 1, 1996; 78(4): 697 - 706. [Abstract] [Full Text]